Moderna begins manufacturing of Covid-19 vaccine at Recipharm site in France
Moderna Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines; and Recipharm, a leading contract development and manufacturing organization, confirmed that following the European Medicines Agency's (EMA) Committee for Human Medicines (CHMP) approval of the Recipharm Monts site on June 11, 2021, drug product manufacture
Moderna Begins Manufacturing Of Covid-19 Vaccine A | 03/07/2021 | By Darshana | 189
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy